Digital Transformation Trend of the Pharmaceutical Distribution Industry in the Context of New Infrastructure in China

Abstract

Objective To study the pharmaceutical distribution industry against the background of new infrastructure construction since it is vital to the health and life of the public, and to offer some suggestions to further improve the industry quality and achieve industry upgrading. Methods The national strategies for new infrastructure as well as the underlying logic for enterprise digital transformation were analyzed to provide the outlook on the digital transformation trend of the pharmaceutical distribution industry. Results and Conclusion In the future, the pharmaceutical distribution industry shall transform the pattern, channel, management and control, and experience in the entire business chain in a digital way by focusing on connection efficiency, data efficiency and decisionmaking efficiency.

Keywords

pharmaceutical distribution / digital transformation / new infrastructure / trend

References

[1] Li Keqiang. Report on the Work of the Government[EB/OL]. (2018-03-22)[2022-03-25]. http://www.gov.cn/guowuyuan/2018-03/22/content_5276608.htm.

[2] Carr NG. IT doesn’t matter[J/OL]. Harvard Business Review, 2003, 81 (5): 41-49 [2003-05]. https://hbr.org/2003/05/it-doesnt-matter.

[3] McKinsey & Company. Industry 4.0 after the initial hype[R]. 2016.

[4] Accenture. 2021 Accenture-Chinese Enterprise Digital Transformation Index Research Report[R]. 2021.

[5] Tencent Research Institute. Thinking on digital transformation of Tencent industry[EB/OL]. (2021-12-14)[2022-03-25]. https://www.tisi.org/22937.

[6] Lou Lihong. Application of the intelligent terminal based on medical IoT technology for drug management process optimization[J]. Journal of Traditional Chinese Medicine Management, 2021, 29 (19): 192-193.

[7] Xu Jing. Analysis on the drug supply chain system underpinned by “Blockchain plus IoT” technology[J]. China Circulation Economy, 2021, 26 (3): 55-57.

[8] Li Manyu, Yu Li. Application research of blockchain for drug traceability[J]. Information Technology and Network Security, 2022, 41 (4): 97-101.

[9] Huo Jiayu. Application research of pharmaceutical cold chain logistics based on blockchain technology[J]. Logistics Engineering and Management, 2022, 44 (3): 46-49.

[10] Wang Hongxia, Lan Wenlong, Wang Zixin, et al. Construction and application of hospital information system integration platform[J]. Infrastructure and Data Management, 2022, 4 (4): 83-85.

[11] Xu Gang. Construction of hospital information system integration platform[J]. Digital Technology and Application, 2022, 40 (1): 211-212+245.

[12] Huang Jiaxin, Zou Yujia, Yi Hongbin, et al. Improvement of consumers’ online drug purchase preference based on O2O model of online pharmacies[J]. China Pharmaceuticals, 2021, 30 (4): 5-9.

[13] Li Sicong, Nie Xiaoyan, Han Sheng, et al. Research on the development of O2O pharmaceutical care mode in China under the internet plus background[J]. China Pharmacy, 2021, 32 (4): 496-501.

[14] Ministry of Commerce. 2021 Statistical Analysis Report on the Operation of Pharmaceutical Distribution Industry[EB/OL]. (2022-09-06)[2022-09-08]. http://images.mofcom.gov.cn/scyxs/202209/20220906181153114.pdf.

[15] General Office of the State Council of the People’s Republic of China. Opinions of the General Office of the State Council on Promoting the Development of “Internet plus Health Care” (GOSC [2018] No. 26)[EB/OL].(2018-04-28)[2022-05-15]. http://www.gov.cn/zhengce/content/2018-04/28/content_5286645.htm.

[16] Zhejiang Medical Products Administration, Health Commission of Zhejiang Province, Healthcare Security Administration of Zhejiang Province. Notice on Printing and Distributing the 2020 Work Plan of Zhejiang Province for Building 24-Hour “Online-booking and Offline-distribution” Pharmacies (ZMPA [2020] No. 4)[EB/OL]. (2020-07-06)[2022-05-22]. http://www.jiaxing.gov.cn/art/2020/7/6/art_1228964143_49920754.html.

[17] The People’s Government of Zhejiang Province. Zhejiang Province saw the establishment of 636 24-hour “online-booking and offline-distribution” pharmacies[EB/OL]. (2020-12-24)[2022-05-22]. http://www.zj.gov.cn/art/2020/12/24/art_1554467_59063087.html.

[18] National Healthcare Security Administration. Guiding Opinions on Vigorously Advancing the Medical Insurance Payment of “Internet Plus” Medical Services (NHSA [2020] No. 45)[EB/OL]. (2020-11-30)[2022-06-18]. http://www.nhsa.gov.cn/art/2020/11/30/art_26_4024.html.

[19] National Healthcare Security Administration. Guiding Opinions of National Health Commission of the People’s Republic of China on Establishing and Improving the “Dual-Channel” Management Mechanism for National Medicare Negotiation Drugs (NHSA [2021] No. 28)[EB/OL]. (2021-05-10)[2022-06-18]. http://www.nhsa.gov.cn/art/2021/5/10/art_37_5023.html.

[20] Department of Market Operation and Consumption Promotion of the Ministry of Commerce. Guiding Opinions of the Ministry of Commerce on Facilitating the High-quality Development of Pharmaceutical Distribution Industry in the 14th Five-Year Plan Period[EB/OL].(2021-10-28)[2022-04-16]. http://www.mofcom.gov.cn/zfxxgk/article/gkml/202110/20211003212444.shtml.